SKP2 and breast cancer: Acquisition of EMT is associated with Skp2 expression in paclitaxel-resistant (PR) breast cancer cells, and Skp2 modulates molecular markers of EMT, including E-cadherin, Vimentin, Snail, and Slug, to enhance tumor metastasis.